According to GuruFocus list of 52-week highs, these Guru stocks have reached their 52-Week Highs: Comcast Corporation (CMCSA, Financial), Eli Lilly & Co. (LLY, Financial), Quest Diagnostics Inc. (DGX, Financial), International Paper Company (IP, Financial) and Roper Industries Inc. (ROP, Financial).
Comcast Corporation (CMCSA) Reached the 52-Week High of $36.54
The prices of Comcast Corporation shares have reached $36.54, which is 0.4% off the 52-week high of $36.67. Comcast Corp., among the world's communication companies, provides basic cable, digital cable and high speed internet services that connect people to what's important in their lives. Comcast Corporation has a market cap of $95.67 billion; its shares were traded at around $36.54 with a P/E ratio of 20.4 and P/S ratio of 1.7. The dividend yield of Comcast Corporation stocks is 1.8%. Comcast Corporation had an annual average earnings growth of 17.1% over the past 10 years. GuruFocus rated Comcast Corporation the business predictability rank of 4-star.
On Aug. 1, Comcast Corporation reported results for the quarter ended June 30, 2012. Revenue increased 6.1% in the second quarter of 2012 to $15.2 billion, while operating cash flow increased 4.2% to $5.0 billion and operating income increased 4.8% to $3.1 billion.
In September, Director Judith Rodin, Executive Vice President Stephen B. Burke and Senior Vice President and Controller Lawrence J. Salva sold shares of CMCSA stock. Vice Chairman and CFO Michael J. Angelakis and Chairman of Board, President and CEO Brian L. Roberts sold shares in May.
Eli Lilly & Co. (LLY) Reached the 52-Week High of $48.23
The prices of Eli Lilly & Co. shares have reached $48.23, which is 1.1% off the 52-week high of $48.77. Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. Eli Lilly & Co. has a market cap of $55.03 billion; its shares were traded at around $48.23 with a P/E ratio of 12.6 and P/S ratio of 2.3. The dividend yield of Eli Lilly & Co. stocks is 4.1%. Eli Lilly & Co. had an annual average earnings growth of 5.3% over the past 10 years. GuruFocus rated Eli Lilly & Co. the business predictability rank of 2.5-star.
On July 25, Eli Lilly & Co. reported results for the second quarter of 2012. In the second quarter of 2012, worldwide total revenue was $5.601 billion, a decrease of 10 percent compared with the second quarter of 2011. Operating income in the second quarter of 2012 was $1.202 billion, a decrease of 24 percent compared to the second quarter of 2011. Net income and earnings per share decreased to $923.6 million and $0.83, respectively, compared with second-quarter 2011 net income of $1.197 billion and earnings per share of $1.07.
In August, Sr. VP & Pres., Lilly Diabetes Enrique A Conterno sold shares of LLY stock. SVP&Pres., Emerging Markets Jacques Tapiero and Sr. VP & Pres., Lilly Diabetes Enrique A Conterno sold shares in June. Chief Accounting Officer Arnold C Hanish sold shares in May.
Quest Diagnostics Inc. (DGX) Reached the 52-Week High of $64.17
The prices of Quest Diagnostics Inc. shares have reached $64.17, which is 0.0% off the 52-week high of $64.17. Quest Diagnostics Inc. is the provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. Quest Diagnostics Inc. has a market cap of $10.07 billion; its shares were traded at around $64.17 with a P/E ratio of 13.6 and P/S ratio of 1.3. The dividend yield of Quest Diagnostics Inc. stocks is 1.1%. Quest Diagnostics Inc. had an annual average earnings growth of 11.4% over the past 10 years. GuruFocus rated Quest Diagnostics Inc. the business predictability rank of 3.5-star.
On July 19, Quest Diagnostics Incorporated announced that for the second quarter ended June 30, 2012, adjusted income from continuing operations was $187 million, or $1.17 per diluted share, compared to $179 million, or $1.12 per diluted share, in 2011.For the second quarter of 2012, reported income from continuing operations was $178 million, or $1.11 per diluted share, compared to $164 million, or $1.02 per diluted share, in 2011. Revenues were $1.9 billion for the second quarter, essentially unchanged compared to 2011.
In August, President and CEO Stephen H. Rusckowski bought 5,000 shares of DGX stock. Last week, Senior Vice President and CFO Robert Hagemann sold 46,667 shares of DGX stock. Director John B. Ziegler sold 10,000 shares in September. Director Gail R. Wilensky, Director William F. Buehler, Director John C. Md Baldwin, Senior Vice President Physician Services Catherine T. Doherty sold shares in August.
International Paper Company (IP) Reached the 52-Week High of $36.81
The prices of International Paper Company shares have reached $36.81, which is 0.7% off the 52-week high of $37.08. International Paper Co. is a global paper and forest products company that is complemented by an extensive distribution system. International Paper Company has a market cap of $15.89 billion; its shares were traded at around $36.81 with a P/E ratio of 13.9 and P/S ratio of 0.6. The dividend yield of International Paper Company stocks is 2.9%. International Paper Company had an annual average earnings growth of 3.3% over the past 10 years.
On July 26, International Paper reported second-quarter 2012 net earnings attributable to common shareholders totaling $134 million ($0.31 per share) compared with net earnings of $188 million ($0.43 per share) in the first quarter of 2012 and $219 million ($0.51 per share) in the second quarter of 2011. Earnings from continuing operations and before special items in the second quarter of 2012 totaled $203 million ($0.46 per share), compared with $247 million ($0.57 per share) in the first quarter of 2012 and $338 million ($0.79 per share) in the second quarter of 2011.
In September, Chairman and CEO John V. Faraci, Senior Vice President Tommy S. Joseph, Senior Vice President Maximo Pacheco, Senior Vice President Mark S. Sutton and Senior Vice President and CIO John N. Balboni sold shares of IP stock. Senior Vice President and CFO Carol L. Roberts sold 7,500 shares in August.
Roper Industries Inc. (ROP) Reached the 52-Week High of $111.22
The prices of Roper Industries Inc. shares have reached $111.22, which is 0.0% off the 52-week high of $111.22. Roper Industries Inc. designs, manufactures and distributes specialty industrial controls, fluid handling and analytical instrumentation products worldwide, serving selected segments of a broad range of markets such as oil & gas, scientific research, medical diagnostics, semiconductor, microscopy, chemical and petrochemical processing, large diesel engine and turbine/compressor control applications, bulk-liquid trucking, power generation, and agricultural irrigation industries. Roper Industries Inc. has a market cap of $10.75 billion; its shares were traded at around $111.22 with a P/E ratio of 23.9 and P/S ratio of 3.8. The dividend yield of Roper Industries Inc. stocks is 0.5%. Roper Industries Inc. had an annual average earnings growth of 16.8% over the past 10 years. GuruFocus rated Roper Industries Inc. the business predictability rank of 3-star.
On July 30, Roper Industries Inc. reported financial results for the second quarter ended June 30, 2012. Net earnings for the second quarter were $115 million, an 8% increase over the second quarter of 2011 and excluding a foreign currency remeasurement gain on intercompany debt in the prior year, net earnings were up 13%. Diluted earnings per share were $1.15. Revenue increased 4% to $725 million. Operating income increased to $179 million and operating margin was 24.7%, a 130 basis point increase over the prior year.
In September, CEO and President Brian D. Jellison, Executive Vice President and CFO John Humphrey and Vice President, General Counsel and Secretary David B. Liner sold shares of ROP stock. Director Christopher Wright and Vice President and Controller Paul J. Soni sold shares in August. Vice President, General Counsel and Secretary David B. Liner sold shares in May and Director Wilbur J. Prezzano sold shares in April.
Comcast Corporation (CMCSA) Reached the 52-Week High of $36.54
The prices of Comcast Corporation shares have reached $36.54, which is 0.4% off the 52-week high of $36.67. Comcast Corp., among the world's communication companies, provides basic cable, digital cable and high speed internet services that connect people to what's important in their lives. Comcast Corporation has a market cap of $95.67 billion; its shares were traded at around $36.54 with a P/E ratio of 20.4 and P/S ratio of 1.7. The dividend yield of Comcast Corporation stocks is 1.8%. Comcast Corporation had an annual average earnings growth of 17.1% over the past 10 years. GuruFocus rated Comcast Corporation the business predictability rank of 4-star.
On Aug. 1, Comcast Corporation reported results for the quarter ended June 30, 2012. Revenue increased 6.1% in the second quarter of 2012 to $15.2 billion, while operating cash flow increased 4.2% to $5.0 billion and operating income increased 4.8% to $3.1 billion.
In September, Director Judith Rodin, Executive Vice President Stephen B. Burke and Senior Vice President and Controller Lawrence J. Salva sold shares of CMCSA stock. Vice Chairman and CFO Michael J. Angelakis and Chairman of Board, President and CEO Brian L. Roberts sold shares in May.
Eli Lilly & Co. (LLY) Reached the 52-Week High of $48.23
The prices of Eli Lilly & Co. shares have reached $48.23, which is 1.1% off the 52-week high of $48.77. Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. Eli Lilly & Co. has a market cap of $55.03 billion; its shares were traded at around $48.23 with a P/E ratio of 12.6 and P/S ratio of 2.3. The dividend yield of Eli Lilly & Co. stocks is 4.1%. Eli Lilly & Co. had an annual average earnings growth of 5.3% over the past 10 years. GuruFocus rated Eli Lilly & Co. the business predictability rank of 2.5-star.
On July 25, Eli Lilly & Co. reported results for the second quarter of 2012. In the second quarter of 2012, worldwide total revenue was $5.601 billion, a decrease of 10 percent compared with the second quarter of 2011. Operating income in the second quarter of 2012 was $1.202 billion, a decrease of 24 percent compared to the second quarter of 2011. Net income and earnings per share decreased to $923.6 million and $0.83, respectively, compared with second-quarter 2011 net income of $1.197 billion and earnings per share of $1.07.
In August, Sr. VP & Pres., Lilly Diabetes Enrique A Conterno sold shares of LLY stock. SVP&Pres., Emerging Markets Jacques Tapiero and Sr. VP & Pres., Lilly Diabetes Enrique A Conterno sold shares in June. Chief Accounting Officer Arnold C Hanish sold shares in May.
Quest Diagnostics Inc. (DGX) Reached the 52-Week High of $64.17
The prices of Quest Diagnostics Inc. shares have reached $64.17, which is 0.0% off the 52-week high of $64.17. Quest Diagnostics Inc. is the provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. Quest Diagnostics Inc. has a market cap of $10.07 billion; its shares were traded at around $64.17 with a P/E ratio of 13.6 and P/S ratio of 1.3. The dividend yield of Quest Diagnostics Inc. stocks is 1.1%. Quest Diagnostics Inc. had an annual average earnings growth of 11.4% over the past 10 years. GuruFocus rated Quest Diagnostics Inc. the business predictability rank of 3.5-star.
On July 19, Quest Diagnostics Incorporated announced that for the second quarter ended June 30, 2012, adjusted income from continuing operations was $187 million, or $1.17 per diluted share, compared to $179 million, or $1.12 per diluted share, in 2011.For the second quarter of 2012, reported income from continuing operations was $178 million, or $1.11 per diluted share, compared to $164 million, or $1.02 per diluted share, in 2011. Revenues were $1.9 billion for the second quarter, essentially unchanged compared to 2011.
In August, President and CEO Stephen H. Rusckowski bought 5,000 shares of DGX stock. Last week, Senior Vice President and CFO Robert Hagemann sold 46,667 shares of DGX stock. Director John B. Ziegler sold 10,000 shares in September. Director Gail R. Wilensky, Director William F. Buehler, Director John C. Md Baldwin, Senior Vice President Physician Services Catherine T. Doherty sold shares in August.
International Paper Company (IP) Reached the 52-Week High of $36.81
The prices of International Paper Company shares have reached $36.81, which is 0.7% off the 52-week high of $37.08. International Paper Co. is a global paper and forest products company that is complemented by an extensive distribution system. International Paper Company has a market cap of $15.89 billion; its shares were traded at around $36.81 with a P/E ratio of 13.9 and P/S ratio of 0.6. The dividend yield of International Paper Company stocks is 2.9%. International Paper Company had an annual average earnings growth of 3.3% over the past 10 years.
On July 26, International Paper reported second-quarter 2012 net earnings attributable to common shareholders totaling $134 million ($0.31 per share) compared with net earnings of $188 million ($0.43 per share) in the first quarter of 2012 and $219 million ($0.51 per share) in the second quarter of 2011. Earnings from continuing operations and before special items in the second quarter of 2012 totaled $203 million ($0.46 per share), compared with $247 million ($0.57 per share) in the first quarter of 2012 and $338 million ($0.79 per share) in the second quarter of 2011.
In September, Chairman and CEO John V. Faraci, Senior Vice President Tommy S. Joseph, Senior Vice President Maximo Pacheco, Senior Vice President Mark S. Sutton and Senior Vice President and CIO John N. Balboni sold shares of IP stock. Senior Vice President and CFO Carol L. Roberts sold 7,500 shares in August.
Roper Industries Inc. (ROP) Reached the 52-Week High of $111.22
The prices of Roper Industries Inc. shares have reached $111.22, which is 0.0% off the 52-week high of $111.22. Roper Industries Inc. designs, manufactures and distributes specialty industrial controls, fluid handling and analytical instrumentation products worldwide, serving selected segments of a broad range of markets such as oil & gas, scientific research, medical diagnostics, semiconductor, microscopy, chemical and petrochemical processing, large diesel engine and turbine/compressor control applications, bulk-liquid trucking, power generation, and agricultural irrigation industries. Roper Industries Inc. has a market cap of $10.75 billion; its shares were traded at around $111.22 with a P/E ratio of 23.9 and P/S ratio of 3.8. The dividend yield of Roper Industries Inc. stocks is 0.5%. Roper Industries Inc. had an annual average earnings growth of 16.8% over the past 10 years. GuruFocus rated Roper Industries Inc. the business predictability rank of 3-star.
On July 30, Roper Industries Inc. reported financial results for the second quarter ended June 30, 2012. Net earnings for the second quarter were $115 million, an 8% increase over the second quarter of 2011 and excluding a foreign currency remeasurement gain on intercompany debt in the prior year, net earnings were up 13%. Diluted earnings per share were $1.15. Revenue increased 4% to $725 million. Operating income increased to $179 million and operating margin was 24.7%, a 130 basis point increase over the prior year.
In September, CEO and President Brian D. Jellison, Executive Vice President and CFO John Humphrey and Vice President, General Counsel and Secretary David B. Liner sold shares of ROP stock. Director Christopher Wright and Vice President and Controller Paul J. Soni sold shares in August. Vice President, General Counsel and Secretary David B. Liner sold shares in May and Director Wilbur J. Prezzano sold shares in April.
